therefore, assessment of the PD-L1 expression level among these subtypes of lung cancer is warranted, since lung cancer is among those malignances wherein PD-L1 expression level is consulted in determining to define role of immunotherapy. The gene discussed is CD274; the disease is lung carcinoma.